PR Newswire: news distribution, targeting and monitoring
52.34 USD  +0.67 (+1.30%)
Official Closing Price  /  Updated: 6:40 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(SNY) Community Analysis from
April 18, 2014
(Stock Blog Hub, 9/26/13)
Peregrine Pharmaceuticals (PPHM) recently received encouraging news when the company announced that the US Food and Drug Administration (FDA) has agreed on the design for...(read more)
(Stock Blog Hub, 8/4/13)
Sanofi (SNY) and partner Regeneron Pharmaceuticals, Inc. (REGN) recently announced that positive data from a phase IIa study evaluating dupilumab...(read more)
(Wealth Daily, 2/13/13)
As part of the companies' ten-year partnership, Sanofi SA (EPA: SAN) will increase its stake in Regeneron Pharmaceuticals (NASDAQ: REGN) to 30%, possibly going beyond that in the years to come...
Sanofi-Aventis SA (SNY) Company Overview

There is no analysis for SNY yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

Online Member Center

Not a Member?
Click Here to Join
Search News Releases
Advanced Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release